Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.
Xian L, Zhao P, Chen X, Wei Z, Ji H, Zhao J, Liu W, Li Z, Liu D, Han X, Qian Y, Dong H, Zhou X, Fan J, Zhu X, Yin J, Tan X, Jiang D, Yu H, Cao G.
Xian L, et al. Among authors: liu w, liu d.
Cell Oncol (Dordr). 2022 Oct;45(5):1019-1036. doi: 10.1007/s13402-022-00707-3. Epub 2022 Aug 29.
Cell Oncol (Dordr). 2022.
PMID: 36036881